Home › Funds › MPM BioImpact LLC › ODTX
MPM BioImpact LLC position in ODTX
ODYSSEY THERAPEUTICS INC · Health Care
MPM BioImpact LLC reported holding 1,289,091 shares of ODTX (ODYSSEY THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$28.6M, representing 2.20% of its reported portfolio and ranking #21 among its reported holdings. MPM BioImpact LLC first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How MPM BioImpact LLC's ODTX position evolved
MPM BioImpact LLC first disclosed a stake in ODTX in Q3 2026 at 1,289,091 shares (US$28.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 1.29M | $28.64M | New |
About ODTX and 13F data
ODTX (ODYSSEY THERAPEUTICS INC) is a Health Care company. 75 other funds we track also report a position in ODTX — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$84.3M), TPG GP A, LLC (US$82.0M), Lightspeed Management Company, L.L.C. (US$80.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ODTX
- SR ONE CAPITAL MANAGEMENT, LP 3.79M sh · $84.32M · Q3 2026
- TPG GP A, LLC 3.69M sh · $82.00M · Q3 2026
- Lightspeed Management Company, L.L.C. 3.61M sh · $80.18M · Q3 2026
- ORBIMED ADVISORS LLC 3.00M sh · $66.69M · Q3 2026
- Sanofi 1.99M sh · $44.22M · Q3 2026
- Affinity Asset Advisors, LLC 1.26M sh · $28.00M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.05M sh · $23.25M · Q3 2026
- Sands Capital Alternatives, LLC 875.00K sh · $19.44M · Q3 2026
- Hillhouse Capital (HHLR Advisors) 831.66K sh · $18.48M · Q3 2026
- General Catalyst Group Management, LLC 810.27K sh · $18.00M · Q3 2026
- Foresite Capital Management V, LLC 729.60K sh · $16.21M · Q3 2026
- Vivo Capital, LLC 575.00K sh · $12.78M · Q3 2026
More on MPM BioImpact LLC
FAQ
How long has MPM BioImpact LLC held ODTX?
MPM BioImpact LLC has disclosed ODTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is MPM BioImpact LLC's current position in ODTX?
As of Q3 2026, MPM BioImpact LLC holds 1.29M shares of ODTX (ODYSSEY THERAPEUTICS INC), valued at $28.64M, representing 2.20% of its reported portfolio and ranking #21.
Has MPM BioImpact LLC been buying or selling ODTX?
In the latest 13F filing (Q3 2026), MPM BioImpact LLC newly opened its position in ODTX.
Which other funds hold ODTX?
Other major institutional holders of ODTX include SR ONE CAPITAL MANAGEMENT, LP, TPG GP A, LLC, Lightspeed Management Company, L.L.C., among 75 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.